West Pharmaceutical Services

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell WST and other ETFs, options, and stocks.

About WST

West Pharmaceutical Services, Inc. engages in the manufacture and marketing of pharmaceuticals, biologics, vaccines, and consumer healthcare products. It operates through the Proprietary Products and Contract-Manufactured Products segments. 

CEO
Eric Mark Green
CEOEric Mark Green
Employees
10,800
Employees10,800
Headquarters
Exton, Pennsylvania
HeadquartersExton, Pennsylvania
Founded
1923
Founded1923
Employees
10,800
Employees10,800

WST Key Statistics

Market cap
17.59B
Market cap17.59B
Price-Earnings ratio
36.56
Price-Earnings ratio36.56
Dividend yield
0.35%
Dividend yield0.35%
Average volume
1.31M
Average volume1.31M
High today
$246.42
High today$246.42
Low today
$241.91
Low today$241.91
Open price
$245.51
Open price$245.51
Volume
243.32K
Volume243.32K
52 Week high
$322.34
52 Week high$322.34
52 Week low
$187.43
52 Week low$187.43

Stock Snapshot

As of today, West Pharmaceutical Services(WST) shares are valued at $244.30. The company's market cap stands at 17.59B, with a P/E ratio of 36.56 and a dividend yield of 34.6%.

On 2026-02-19, West Pharmaceutical Services(WST) stock traded between a low of $241.91 and a high of $246.42. Shares are currently priced at $244.30, which is +1.0% above the low and -0.9% below the high.

West Pharmaceutical Services(WST) shares are trading with a volume of 243.32K, against a daily average of 1.31M.

During the past year, West Pharmaceutical Services(WST) stock moved between $187.43 at its lowest and $322.34 at its peak.

During the past year, West Pharmaceutical Services(WST) stock moved between $187.43 at its lowest and $322.34 at its peak.

WST News

Simply Wall St 8h
Assessing West Pharmaceutical Services Valuation After New US$1b Buyback And Earnings Update

West Pharmaceutical Services (WST) has paired a new share repurchase plan of up to US$1b with its regular US$0.22 quarterly dividend and recently reported 2025...

Assessing West Pharmaceutical Services Valuation After New US$1b Buyback And Earnings Update
TipRanks 12h
Customer Concentration Risk: How Dependence on Key Accounts Threatens West Pharmaceutical’s Financial Stability

West Pharmaceutical Services, Inc. (WST) has disclosed a new risk, in the Sales & Marketing category. West Pharmaceutical Services, Inc. relies heavily on a re...

24/7 Wall St. 4d
West Pharmaceutical’s Under-the-Radar Dividend Worth Watching

West Pharmaceutical’s Under-the-Radar Dividend Worth Watching Quick Read West Pharmaceutical Services (WST) yields 0.34% but grew dividends 73% since 2016 with...

West Pharmaceutical’s Under-the-Radar Dividend Worth Watching

Analyst ratings

78%

of 18 ratings
Buy
77.8%
Hold
22.2%
Sell
0%

More WST News

Simply Wall St 4d
How Investors Are Reacting To West Pharmaceutical GLP-1 Momentum And Upbeat 2026 Sales Guidance

In February 2026, West Pharmaceutical Services reported that fourth-quarter 2025 sales rose to US$805.0 million with net income of US$132.1 million, and issued...

How Investors Are Reacting To West Pharmaceutical GLP-1 Momentum And Upbeat 2026 Sales Guidance
TipRanks 6d
West Pharmaceutical price target lowered to $300 from $370 at BofA

BofA lowered the firm’s price target on West Pharmaceutical (WST) to $300 from $370 and keeps a Buy rating on the shares after “a solid finish to the year” and...

People also own

Based on the portfolios of people who own WST. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.